Vir Biotechnology, Inc. is a clinical-stage immunology company based in San Francisco, California, dedicated to transforming the treatment landscape for serious infectious diseases. The company is harnessing its proprietary technologies to develop a diverse pipeline of monoclonal antibodies and immunotherapeutics, with a particular focus on high-impact viral infections such as COVID-19 and influenza. Supported by strategic collaborations, Vir is enhancing its research capabilities and positioning itself as a significant player in the biotechnology sector, committed to addressing critical unmet health needs and improving global health outcomes. Show more

Location: 1800 OWENS STREET, SAN FRANCISCO, CA, UNITED STATES, 94158, San Francisco, CA, 94158, USA | Website: https://www.vir.bio | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

962.7M

52 Wk Range

$4.16 - $10.09

Previous Close

$6.92

Open

$7.06

Volume

1,864,842

Day Range

$7.04 - $7.40

Enterprise Value

638.5M

Cash

170.1M

Avg Qtr Burn

-167.6M

Insider Ownership

10.39%

Institutional Own.

78.45%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Tobevibart + Elebsiran Details Hepatitis Delta Virus	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Sotrovimab VIR-7831 (GSK4182136) Details COVID-19, Infectious disease	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tobevibart (VIR-3434) + Elebsiran (VIR-2218) Details Infectious disease, Hepatitis B	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VIR-3434 +/- VIR-2218 +/- PEG-IFNα Details Infectious disease, Hepatitis B	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VIR-2482 (Universal prophylaxis) Details Influenza, Infectious disease	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VIR-5525 Details Cancer, Head and neck squamous cell carcinoma, Non-small cell lung carcinoma, Metastatic colorectal cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VIR-5818 + Pembrolizumab Details Cancer, HER2-expressing cancers, Metastatic breast cancer, Metastatic colorectal cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VIR-5500 + ARPIs Details Metastatic castration resistant prostate cancer (mCRPC)	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VIR-1388 (HVTN 142) Details Infectious disease, Human immunodeficiency virus, Vaccine	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VIR-1111 Details Infectious disease, Human immunodeficiency virus, Vaccine	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Sotrovimab VIR-7831 (GSK4182136) Details COVID-19, Infectious disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.